🔴 WE ARE LIVE

TWN is thrilled to organize with the United Nations University - IIGH (@unu-iigh.bsky.social) the Symposium Strengthening Global Health Governance: Defending the Public Interest and Holding Powerful Private Actors Accountable.

Watch here ▶️ shorturl.at/eSMyO

Join us

TWN & @unu-iigh.bsky.social are organizing this event for civil society & academia to examine the influence of private actors in global health & discuss avenues for action.

🗓️April 22 | 9:00 MYT
📍In-person registration: shorturl.at/7TLqM
💻Attend online: shorturl.at/eSMyO

Indian generic company Natco Pharma just announced rare disease drug Risdiplam could cost 97% less.

For TWN, this price difference should prime other countries to follow & allow generic manufacturing in the promotion of public interest.

Full report ▶️ shorturl.at/EN2D8

🚨New Report

AI is now designing & modifying DNA, but its decisions are a “black box”—untraceable & risky. Impact on biodiversity, biosecurity & the environment is huge.

Read further in our latest report with @etcgroup.bsky.social & the African Center for Biodiversity.

⏬ shorturl.at/pB3ba

To clarify its complexities, we have created a mpox timeline.

The timeline highlights the deployment of vaccines, therapeutics, and diagnostics, while exposing inequalities in access and Africa’s long-standing burden.

See here ➡️ twn.my/files/202412...

🌍 Mpox should be a global wake-up call

In our new podcast episode, we interview Chetali Rao, a lawyer & scientist who traces the virus's trends, outbreaks & medical responses to highlight the ethical, legal & equity issues they raise.

Tune in🎧 www.buzzsprout.com/2388994/epis...

Developing countries expected that developed countries would drive climate finance mobilization. But the COP outcome aims low and dilutes responsibility.

🎧Meena Raman, Program Director at TWN, breaks down #COP29 in Baku.

www.bfm.my/podcast/the-...

Africa Group & Brazil call out global pressures from developed countries against TRIPS flexibilities at WIPO.

A UN report about these cases said this violates the integrity and legitimacy of the rights and duties in the TRIPS Agreement.

Full report 🔗 www.twn.my/title2/intel...

Roche targets Indian generic Zydus –that produces generic cancer drug– citing lapses like missing approvals & trial material issues.

But Roche's claims seem more about blocking affordable biosimilars than compliance.

Full report 🔗 www.twn.my/title2/intel...